ASSOCHAM Webinar & Report Launch on “Rising Burden of Non–Communicable Diseases In India”

22 July, 2021

About Event



Non
Communicable Diseases (NCDs) are also commonly referred to chronic diseases are growing menace and has attracted attention in recent years as it affects persons irrespective of gender and age, every country irrespective of income, and due to alarming socio-economic burden that they impose. The WHO estimated that, by 2020, NCDs will account for 80% of the global burden of disease, causing seven out of every 10 deaths in developing countries with roughly half of those deaths occurring prematurely to persons younger than 70 years of age.
 
Globally, every three of four people die because of NCDs. In 2017, NCDs were responsible for 41.1 million of the world’s 55.95 million deaths. NCDs such as cardio-vascular diseases (CVDs), cancer, diabetes and chronic respiratory diseases are the leading global cause of death and are responsible for 70% of deaths worldwide.
 
NCDs continue to be an important public health problem in India, being responsible for a major proportion of mortality and morbidity. As compared to 1990s when there only 40 percent of chances of people dying of a NCDs, the risk of people dying with NCDs is more than 1.5 times today. Global burden of disease report that in 2017, 63.5 percent of 9.9 million deaths in India occurred due to NCDs. In 1990s, top five individual causes of disease burden were all communicable diseases whereas in 2017, three of top five causes are NCDs.  The worrying part is it result significant to most productive years of life, between 15-69 years, where Indians with years live with disability (YLDs) account for 90.35 million years.
 
The current research by ASSOCHAM and Thought Arbitrage Research Institute (TARI) titled “Non-Communicable Diseases In India” suggests that the prevalence of having any NCDs among the population is 116 per 1000 population in India, and shows a quantum jump among individuals above 35 years of age. It identified hypertension, digestive disease, and diabetes as the top three NCDs followed by respiratory diseases, brain/neurological disorders, heart diseases/CVD, kidney disorders, and cancer in the order of prevalence.
 
The Covid-19 pandemic has brought a sharper focus on health care. Patterns emerging from Covid management across the country indicate that people with co-morbidities of non-communicable diseases (NCDs) have a higher mortality rate than those who do not. This has grave implications for the country not only because of mortality and years of healthy lives lost but also because of India’s health infrastructure.
 
With the objective to discuss on causes, effects and strategize on the plans to reduce the burden of NCDs in India, ASSOCHAM is organising a webinar on “Rising Burden of Non–Communicable Diseases In India” on Thursday, 22nd July, 2021, 3.00 PM To 4.30 PM, where the study on the subject will also be released.
 
Invited Speakers
1.    (Padma Bhushan) Prof. (Dr.) Shiv Kumar Sarin, Head, Department of Hepatology & Director, Institute of Liver and Biliary Sciences, New Delhi
2.    (Padma Bhushan) Dr. K. K. Talwar Chairman, PSRI Heart Institute Former HoD, Cardiology AIIMS, New Delhi & Director, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh
3.    (Padma Bhushan) Dr. Ambrish Mithal Chairman & Head, Endocrinology and Diabetes, Department, Max Healthcare (Pan Max)
4.    Prof. (Dr.) Rajinder K. Dhamija, Head of Neurology Department, Lady Hardinge Medical College, New Delhi
5.    Dr. G C Khilnani, Ex Head & Professor, Department of Pulmonary Medicine & Sleep Disorders, AIIMS, New Delhi and Chairman, PSRI Institute of Pulmonary Critical Care & Sleep Medicine
6.    Dr. Shikha Halder, Director & Senior Consultant, Department of Radiation Oncology, BLK-Max Super Specialty Hospitals
7.    Mr. Kaushik Dutta, Founder and Co-Director, Thought Arbitrage Research Institute (TARI)
8.    Dr. Rajesh Kesari, Founder and Director, Total Care Control
 
Registration Link: https://bit.ly/3erd4LP

Prior registration is mandatory. We shall appreciate your kind consideration and an early confirmation for the program.